SpineGuard Nabs $6.2M
SpineGuard has added $6.2 million in funding to expand its platform for enhanced spinal screw placement, which is designed to make spine surgery safer. Investors included Credit Agricole Private Equity, Innoven Partenaires, A Plus Finance, and Delta Partners. SpineGuard has offices in San Francisco and Paris.
PRESS RELEASE
SpineGuard announced today that it has secured $6.2 million to further extend its PediGuard platform for enhanced spinal screw placement. The company launched PediGuard Curv earlier this year and is preparing for the limited release of its highly anticipated Cannulated PediGuard, a “smart needle” to address minimally invasive spine surgery. The Company’s initial breakthrough product is PediGuard Classic.
Investors included Credit Agricole Private Equity, Innoven Partenaires, A Plus Finance, and Delta Partners.
“This additional funding to support further extension of the PediGuard franchise bears strong testimony not only to the clinical need for PediGuard but also management’s track record and strategy to grow the company,” said Alexia Perouse, Partner at Credit Agricole Private Equity and a Director of SpineGuard.
“This new financing...
